CSIMarket
 
Biocorrx Inc   (BICX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $0.9200 $-0.08 -7.538%
Day's High: $0.92 Week Perf: -8 %
Day's Low: $ 0.92 30 Day Perf: 31.43 %
Volume (M): 0 52 Wk High: $ 2.22
Volume (M$): $ 0 52 Wk Avg: $1.43
Open: $0.92 52 Wk Low: $0.67



 Market Capitalization (Millions $) 8
 Shares Outstanding (Millions) 9
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Biocorrx Inc
Biocorrx Inc is a healthcare company that specializes in developing and providing innovative solutions for the treatment of substance use disorders. The company's main focus is on developing medication-assisted treatment programs that combine pharmaceuticals with counseling and support to help individuals overcome addiction. Biocorrx's flagship product is the BICX101, an implantable, biodegradable pellet that delivers medication for the treatment of alcohol and opioid dependence. The company also provides support services to healthcare professionals and patients, including physician training, counseling, and aftercare. Biocorrx Inc aims to improve patient outcomes and revolutionize the way substance use disorders are treated.


   Company Address: 2390 East Orangewood Avenue Anaheim 92806 CA
   Company Phone Number: 462-4880   Stock Exchange / Ticker: BICX
   BICX is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Biocorrx Inc

Biocorrx Inc faces a make-or-break period as it navigates the pivotal July to September 2023 quarter

Biocorrx Inc, a healthcare facilities company, has recently released its financial report for the fiscal period ending September 30, 2023. The report reveals several interesting facts about the company's performance during that time.
One of the key highlights is the improvement in Biocorrx Inc's earnings per share (EPS). In comparison to the previous year, where the company had a loss per share of $-0.13, the fiscal period ending September 30, 2023, showed a reduced loss per share of $-0.10. Additionally, EPS improved from $-0.11 per share in the previous reporting season, indicating positive growth.

Biocorrx Inc

Biocorrx Inc Delivers Impressive Financial Results with Strong Top-line Surge in Q2 2023

Biocorrx Inc Shows Improvement in Financial Performance
Biocorrx Inc, a healthcare facilities company, has reported a positive financial second quarter for 2023. The company decreased its loss per share from $-0.19 to $-0.11 compared to the previous year, showing an improvement in performance. Additionally, earnings per share also improved from $-0.13 to $-0.11 in the prior reporting season.
In terms of revenue, Biocorrx Inc experienced a rapid increase of 22.703% to $0.02 million, compared to the same reporting season a year prior. However, there was a sequential decrease in revenue by -51.449% from $0.04 million. Despite this decline, Biocorrx Inc has outperformed its sector peers in terms of revenue advancement, as the Healthcare Facilities sector showed a modest 8.08% increase during the same period.

Biocorrx Inc

Biocorrx Inc Outperforms Projections, Recorded a Minimal Deficit of $-0.13 per Share in Q1 2023!

19 as it is not mentioned in the financial results.

Biocorrx Inc, a healthcare facilities company, has reported improving financial results for the first quarter of 2023, demonstrating that they are on track to generate positive cash flow for the company. The most significant improvement in their financial metrics has been in the area of outstanding accounts receivable, which shows that they are effectively managing their liquidity and credit risk.






 

Biocorrx Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com